Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerance of intra-articular autologous stromal vascular fraction in rhizarthrosis
2022-001784-27Phase 2Active
- Sponsor
- Direction de la Recherche Clinique et de l'Innovation
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous adipose-derived stromal vascular fraction in Rhizarthrosis, sponsored by Direction de la Recherche Clinique et de l'Innovation. Started May 2022; status: active.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on 2022-001784-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001784-27.